BOTOX® Gets UK Authorization For Urinary Leakage In Patients With Multiple Sclerosis, Spinal Cord Injury

BOTOX(R) has been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) for the management of urinary incontinence in adult patients with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury (SCI) (traumatic or non-traumatic) or multiple sclerosis (MS), who are not adequately managed with anticholinergics.  read more

Read the whole article on

More from